Drug name - Prolensa

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8129431 BAUSCH AND LOMB Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
Sep, 2025

(2 years from now)

CN100341498C BAUSCH AND LOMB Containing 2-Amino - -3-(4-Bromine-Benzoyl) Phenylacetic Acid Aqueous Liquid Preparation
Jan, 2024

(1 year, 3 months from now)

CN1700913A BAUSCH AND LOMB Containing 2-Amino - -3-(4-Bromine-Benzoyl) Phenylacetic Acid Aqueous Liquid Preparation
Jan, 2024

(1 year, 3 months from now)

EP1586316A1 BAUSCH AND LOMB Aqueous Liquid Preparation Containing 2-Amino-3-(4-Bromobenzoyl)Phenylacetic Acid
Jan, 2024

(1 year, 3 months from now)

EP1586316A4 BAUSCH AND LOMB Aqueous Liquid Preparation Containing 2-Amino-3-(4-Bromobenzoyl)Phenylacetic Acid
Jan, 2024

(1 year, 3 months from now)

EP1586316B1 BAUSCH AND LOMB Aqueous Liquid Preparation Containing 2-Amino-3-(4-Bromobenzoyl)Phenylacetic Acid
Jan, 2024

(1 year, 3 months from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9561277 BAUSCH AND LOMB Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid Jan, 2024

(1 year, 3 months from now)

US9144609 BAUSCH AND LOMB Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid Jan, 2024

(1 year, 3 months from now)

US8927606 BAUSCH AND LOMB Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid Jan, 2024

(1 year, 3 months from now)

US8669290 BAUSCH AND LOMB Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid Jan, 2024

(1 year, 3 months from now)

US8754131 BAUSCH AND LOMB Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid Jan, 2024

(1 year, 3 months from now)

US8871813 BAUSCH AND LOMB Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid Jan, 2024

(1 year, 3 months from now)

US10085958 BAUSCH AND LOMB Bromfenac bioavailability Nov, 2032

(10 years from now)

US9517220 BAUSCH AND LOMB Bromfenac bioavailability Nov, 2033

(11 years from now)

Drugs and Companies using BROMFENAC SODIUM ingredient

Treatment: Treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery; Method of treating ocular inflammation; method of treating ocular inflammation; method of treatment to alleviate inflammation of the eye

Dosage: SOLUTION/DROPS;OPHTHALMIC

More Information on Dosage
Strength Dosage Availability
EQ 0.07% ACID SOLUTION/DROPS;OPHTHALMIC Prescription

availability in other generic markets.

Click on the highlighted region to filter.